11 episodes

In Sanofi Genzyme’s podcast “The MS Podcast”, the focus is on Multiple Sclerosis and brain health. Through the different episodes we talk to various specialists within neuroscience, psychology and physical activity to help shed light on the many aspects of treating MS. Tune in and learn more!

The MS Podcast Sanofi Genzyme

    • Health & Fitness

In Sanofi Genzyme’s podcast “The MS Podcast”, the focus is on Multiple Sclerosis and brain health. Through the different episodes we talk to various specialists within neuroscience, psychology and physical activity to help shed light on the many aspects of treating MS. Tune in and learn more!

    Cognitive decline – the invisible burden of MS?

    Cognitive decline – the invisible burden of MS?

    What happens when our cognitive functioning is challenged – which is the case for many people living with MS? To shed some light on the impact of cognitive decline and the future perspectives for cognitive rehabilitation in MS, we have the pleasure of having Hanneke Hulst, assistant professor from the MS center in Amsterdam, (Amsterdam UMC – VUmc), in the studio for this episode.
    October, 2020.
    GZNO.MS.19.11.0310

    • 25 min
    A promising biomarker in MS: Neurofilament light chain

    A promising biomarker in MS: Neurofilament light chain

    Biomarkers are important in MS, as they can potentially help with diagnosing patients, inform about disease prognosis, and help monitor disease activity and progression. Neurofilament light chain (NfL) is one of the most promising biomarkers in MS, but is it ready for clinical practice? In this episode, Professor of Neurology Finn Sellebjerg will tell us about the potential and limitations of this exciting biomarker. GZNO.MS.19.11.0310

    • 22 min
    Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

    Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

    In this episode we’ll talk more about what hides behind the structures of our brain, in the core of the thalamus. Thalamic atrophy measurements have existed for a long time, but within MS it is quite new to look into the thalamic atrophy, also as a biomarker. Today’s guest, Prof. Dr. Cristina Granziera, will tell us more about how knowledge about thalamic atrophy can be implemented in clinical practice.

    GZNO.MS.19.11.0310

    • 25 min
    The importance of Deep Grey matter in MS

    The importance of Deep Grey matter in MS

    MS has long been considered a disease of focal white matter lesions, but recent studies have highlighted the importance of diffuse occult brain damage. Are we facing a paradigm shift? In this episode we'll talk to Dr. Jens Wuerfel about deep grey matter atrophy and advanced imaging to reveal and quantify occult damage of the CNS.

    GZNO.MS.19.11.0310

    • 13 min
    Measuring brain atrophy. What can be done and where are we heading?

    Measuring brain atrophy. What can be done and where are we heading?

    Guest host Svend Geertsen, Medical Advisor for MS in Sanofi Genzyme Denmark, will in this episode discuss the relevance and challenges with measuring brain atrophy with brain imaging experts Morten Blinkenberg, Senior Consultant at the Danish Multiple Sclerosis Center at Rigshospitalet, and Professor Hartwig Siebner, Head of Research at the Danish Research Centre for Magnetic Resonance at Hvidovre Hospital.

    GZNO.MS.19.11.0310

    • 37 min
    The reason for MS – beyond focal inflammation

    The reason for MS – beyond focal inflammation

    Professor Gavin Giovannoni will in this episode tell us more about the "real MS" - why we should stop focusing only on relapses and MRI activity, but rather go beyond and look at end organ damage or accelerated brain loss.

    GZNO.MS.19.11.0310

    • 20 min

Top Podcasts In Health & Fitness

Listeners Also Subscribed To